Feasibility and efficacy of Thulium:YAG laser enucleation (VapoEnucleation) of the prostate.
Identifieur interne : 000527 ( PubMed/Checkpoint ); précédent : 000526; suivant : 000528Feasibility and efficacy of Thulium:YAG laser enucleation (VapoEnucleation) of the prostate.
Auteurs : T. Bach [Allemagne] ; G. Wendt-Nordahl ; M S Michel ; T R W. Herrmann ; A J GrossSource :
- World journal of urology [ 1433-8726 ] ; 2009.
Descripteurs français
- KwdFr :
- Adulte d'âge moyen, Humains, Hyperplasie de la prostate (), Hémorragie postopératoire (étiologie), Infections urinaires (étiologie), Lasers à solide (effets indésirables), Lasers à solide (usage thérapeutique), Mâle, Résultat thérapeutique, Sujet âgé, Sujet âgé de 80 ans ou plus, Thulium (effets indésirables), Thulium (usage thérapeutique), Études de faisabilité, Études prospectives.
- MESH :
- effets indésirables : Lasers à solide, Thulium.
- usage thérapeutique : Lasers à solide, Thulium.
- étiologie : Hémorragie postopératoire, Infections urinaires.
- Adulte d'âge moyen, Humains, Hyperplasie de la prostate, Mâle, Résultat thérapeutique, Sujet âgé, Sujet âgé de 80 ans ou plus, Études de faisabilité, Études prospectives.
English descriptors
- KwdEn :
- Aged, Aged, 80 and over, Feasibility Studies, Humans, Lasers, Solid-State (adverse effects), Lasers, Solid-State (therapeutic use), Male, Middle Aged, Postoperative Hemorrhage (etiology), Prospective Studies, Prostatic Hyperplasia (surgery), Thulium (adverse effects), Thulium (therapeutic use), Treatment Outcome, Urinary Tract Infections (etiology).
- MESH :
- chemical , adverse effects : Thulium.
- adverse effects : Lasers, Solid-State.
- etiology : Postoperative Hemorrhage, Urinary Tract Infections.
- surgery : Prostatic Hyperplasia.
- therapeutic use : Lasers, Solid-State, Thulium.
- Aged, Aged, 80 and over, Feasibility Studies, Humans, Male, Middle Aged, Prospective Studies, Treatment Outcome.
Abstract
Thulium:YAG (Tm:YAG) vaporesection has been introduced and efficiency was shown on smaller prostates. Criticism mainly referred to prolonged operation time in larger prostates, which appears to be a potential limitation compared to HoLEP. Aim of the study was to evaluate feasibility and efficiency of Tm:YAG VapoEnucleation in larger prostates.
DOI: 10.1007/s00345-008-0370-0
PubMed: 19184038
Affiliations:
Links toward previous steps (curation, corpus...)
Links to Exploration step
pubmed:19184038Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Feasibility and efficacy of Thulium:YAG laser enucleation (VapoEnucleation) of the prostate.</title><author><name sortKey="Bach, T" sort="Bach, T" uniqKey="Bach T" first="T" last="Bach">T. Bach</name><affiliation wicri:level="3"><nlm:affiliation>Department of Urology, Asklepios Hospital Barmbek, Hamburg, Germany. thorsten.bach@uro.ma.uni-heidelberg.de</nlm:affiliation><country xml:lang="fr">Allemagne</country><wicri:regionArea>Department of Urology, Asklepios Hospital Barmbek, Hamburg</wicri:regionArea><placeName><settlement type="city">Hambourg</settlement><region type="land" nuts="2">Hambourg</region></placeName></affiliation></author><author><name sortKey="Wendt Nordahl, G" sort="Wendt Nordahl, G" uniqKey="Wendt Nordahl G" first="G" last="Wendt-Nordahl">G. Wendt-Nordahl</name></author><author><name sortKey="Michel, M S" sort="Michel, M S" uniqKey="Michel M" first="M S" last="Michel">M S Michel</name></author><author><name sortKey="Herrmann, T R W" sort="Herrmann, T R W" uniqKey="Herrmann T" first="T R W" last="Herrmann">T R W. Herrmann</name></author><author><name sortKey="Gross, A J" sort="Gross, A J" uniqKey="Gross A" first="A J" last="Gross">A J Gross</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2009">2009</date><idno type="doi">10.1007/s00345-008-0370-0</idno><idno type="RBID">pubmed:19184038</idno><idno type="pmid">19184038</idno><idno type="wicri:Area/PubMed/Corpus">000545</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000545</idno><idno type="wicri:Area/PubMed/Curation">000545</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000545</idno><idno type="wicri:Area/PubMed/Checkpoint">000545</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000545</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Feasibility and efficacy of Thulium:YAG laser enucleation (VapoEnucleation) of the prostate.</title><author><name sortKey="Bach, T" sort="Bach, T" uniqKey="Bach T" first="T" last="Bach">T. Bach</name><affiliation wicri:level="3"><nlm:affiliation>Department of Urology, Asklepios Hospital Barmbek, Hamburg, Germany. thorsten.bach@uro.ma.uni-heidelberg.de</nlm:affiliation><country xml:lang="fr">Allemagne</country><wicri:regionArea>Department of Urology, Asklepios Hospital Barmbek, Hamburg</wicri:regionArea><placeName><settlement type="city">Hambourg</settlement><region type="land" nuts="2">Hambourg</region></placeName></affiliation></author><author><name sortKey="Wendt Nordahl, G" sort="Wendt Nordahl, G" uniqKey="Wendt Nordahl G" first="G" last="Wendt-Nordahl">G. Wendt-Nordahl</name></author><author><name sortKey="Michel, M S" sort="Michel, M S" uniqKey="Michel M" first="M S" last="Michel">M S Michel</name></author><author><name sortKey="Herrmann, T R W" sort="Herrmann, T R W" uniqKey="Herrmann T" first="T R W" last="Herrmann">T R W. Herrmann</name></author><author><name sortKey="Gross, A J" sort="Gross, A J" uniqKey="Gross A" first="A J" last="Gross">A J Gross</name></author></analytic><series><title level="j">World journal of urology</title><idno type="eISSN">1433-8726</idno><imprint><date when="2009" type="published">2009</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Aged</term><term>Aged, 80 and over</term><term>Feasibility Studies</term><term>Humans</term><term>Lasers, Solid-State (adverse effects)</term><term>Lasers, Solid-State (therapeutic use)</term><term>Male</term><term>Middle Aged</term><term>Postoperative Hemorrhage (etiology)</term><term>Prospective Studies</term><term>Prostatic Hyperplasia (surgery)</term><term>Thulium (adverse effects)</term><term>Thulium (therapeutic use)</term><term>Treatment Outcome</term><term>Urinary Tract Infections (etiology)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Adulte d'âge moyen</term><term>Humains</term><term>Hyperplasie de la prostate ()</term><term>Hémorragie postopératoire (étiologie)</term><term>Infections urinaires (étiologie)</term><term>Lasers à solide (effets indésirables)</term><term>Lasers à solide (usage thérapeutique)</term><term>Mâle</term><term>Résultat thérapeutique</term><term>Sujet âgé</term><term>Sujet âgé de 80 ans ou plus</term><term>Thulium (effets indésirables)</term><term>Thulium (usage thérapeutique)</term><term>Études de faisabilité</term><term>Études prospectives</term></keywords><keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en"><term>Thulium</term></keywords><keywords scheme="MESH" qualifier="adverse effects" xml:lang="en"><term>Lasers, Solid-State</term></keywords><keywords scheme="MESH" qualifier="effets indésirables" xml:lang="fr"><term>Lasers à solide</term><term>Thulium</term></keywords><keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Postoperative Hemorrhage</term><term>Urinary Tract Infections</term></keywords><keywords scheme="MESH" qualifier="surgery" xml:lang="en"><term>Prostatic Hyperplasia</term></keywords><keywords scheme="MESH" qualifier="therapeutic use" xml:lang="en"><term>Lasers, Solid-State</term><term>Thulium</term></keywords><keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Lasers à solide</term><term>Thulium</term></keywords><keywords scheme="MESH" qualifier="étiologie" xml:lang="fr"><term>Hémorragie postopératoire</term><term>Infections urinaires</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Aged</term><term>Aged, 80 and over</term><term>Feasibility Studies</term><term>Humans</term><term>Male</term><term>Middle Aged</term><term>Prospective Studies</term><term>Treatment Outcome</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Adulte d'âge moyen</term><term>Humains</term><term>Hyperplasie de la prostate</term><term>Mâle</term><term>Résultat thérapeutique</term><term>Sujet âgé</term><term>Sujet âgé de 80 ans ou plus</term><term>Études de faisabilité</term><term>Études prospectives</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Thulium:YAG (Tm:YAG) vaporesection has been introduced and efficiency was shown on smaller prostates. Criticism mainly referred to prolonged operation time in larger prostates, which appears to be a potential limitation compared to HoLEP. Aim of the study was to evaluate feasibility and efficiency of Tm:YAG VapoEnucleation in larger prostates.</div></front></TEI><pubmed><MedlineCitation Owner="NLM" Status="MEDLINE"><PMID Version="1">19184038</PMID><DateCreated><Year>2009</Year><Month>08</Month><Day>04</Day></DateCreated><DateCompleted><Year>2009</Year><Month>12</Month><Day>31</Day></DateCompleted><DateRevised><Year>2013</Year><Month>11</Month><Day>21</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1433-8726</ISSN><JournalIssue CitedMedium="Internet"><Volume>27</Volume><Issue>4</Issue><PubDate><Year>2009</Year><Month>Aug</Month></PubDate></JournalIssue><Title>World journal of urology</Title><ISOAbbreviation>World J Urol</ISOAbbreviation></Journal><ArticleTitle>Feasibility and efficacy of Thulium:YAG laser enucleation (VapoEnucleation) of the prostate.</ArticleTitle><Pagination><MedlinePgn>541-5</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00345-008-0370-0</ELocationID><Abstract><AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">Thulium:YAG (Tm:YAG) vaporesection has been introduced and efficiency was shown on smaller prostates. Criticism mainly referred to prolonged operation time in larger prostates, which appears to be a potential limitation compared to HoLEP. Aim of the study was to evaluate feasibility and efficiency of Tm:YAG VapoEnucleation in larger prostates.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">VapoEnucleation was performed using a 70 W continuous wave-laser. After enucleation tissue was morcellated within the bladder. Prospectively assessed outcomes were improvement in urodynamic parameter and the intra- and postoperative course. Complications were recorded.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 88 consecutive patients with prostatic enlargement underwent VapoEnucleation. Prostatic volume was 61.3 +/- 24.0 cc (30-160). OR-time was 72 min +/- 26.6 (35-144) and laser-time 32.4 +/- 10.1 min (16.3-59.3). Applied laser energy was 123.7 +/- 40.6 kJ (67.8-240.9). An average of 31.7 +/- 18.3 g of tissue was retrieved. Pathology revealed four patients with incidental carcinoma. Foley catheter-time was 2 days and the suprapubic tube, if placed, was removed on the third postoperative day on average. Twelve complications were recorded, including bleeding (3), urinary tract infection (6), second-look procedure, due to insufficient deobstruction (2). Re-catherization after successful initial voiding trial was necessary in one patient. Mean peak flow rate improved from 3.5 +/- 4.7 to 19.8 +/- 11.6 ml/s and post-voiding residual urine decreased from 121.4 +/- 339.9 to 22.4 +/- 32.7 ml.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">The functional outcomes demonstrate efficiency of Tm:YAG VapoEnucleation for patients with larger prostates. From our experience, learning curve in VapoEnucleation is short and complications are minimal. Theoretically, no limitation in prostate size occurs. Long-term follow-up is needed to prove durability.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Bach</LastName><ForeName>T</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Urology, Asklepios Hospital Barmbek, Hamburg, Germany. thorsten.bach@uro.ma.uni-heidelberg.de</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wendt-Nordahl</LastName><ForeName>G</ForeName><Initials>G</Initials></Author><Author ValidYN="Y"><LastName>Michel</LastName><ForeName>M S</ForeName><Initials>MS</Initials></Author><Author ValidYN="Y"><LastName>Herrmann</LastName><ForeName>T R W</ForeName><Initials>TR</Initials></Author><Author ValidYN="Y"><LastName>Gross</LastName><ForeName>A J</ForeName><Initials>AJ</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D023362">Evaluation Studies</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2009</Year><Month>01</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>World J Urol</MedlineTA><NlmUniqueID>8307716</NlmUniqueID><ISSNLinking>0724-4983</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>8RKC5ATI4P</RegistryNumber><NameOfSubstance UI="D013932">Thulium</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName MajorTopicYN="N" UI="D000368">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D000369">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D005240">Feasibility Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D053844">Lasers, Solid-State</DescriptorName><QualifierName MajorTopicYN="N" UI="Q000009">adverse effects</QualifierName><QualifierName MajorTopicYN="Y" UI="Q000627">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D008875">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D019106">Postoperative Hemorrhage</DescriptorName><QualifierName MajorTopicYN="N" UI="Q000209">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D011446">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D011470">Prostatic Hyperplasia</DescriptorName><QualifierName MajorTopicYN="Y" UI="Q000601">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D013932">Thulium</DescriptorName><QualifierName MajorTopicYN="N" UI="Q000009">adverse effects</QualifierName><QualifierName MajorTopicYN="Y" UI="Q000627">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D016896">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D014552">Urinary Tract Infections</DescriptorName><QualifierName MajorTopicYN="N" UI="Q000209">etiology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2008</Year><Month>11</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2008</Year><Month>12</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="aheadofprint"><Year>2009</Year><Month>1</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2009</Year><Month>2</Month><Day>3</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2009</Year><Month>2</Month><Day>3</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2010</Year><Month>1</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="doi">10.1007/s00345-008-0370-0</ArticleId><ArticleId IdType="pubmed">19184038</ArticleId></ArticleIdList></PubmedData></pubmed><affiliations><list><country><li>Allemagne</li></country><region><li>Hambourg</li></region><settlement><li>Hambourg</li></settlement></list><tree><noCountry><name sortKey="Gross, A J" sort="Gross, A J" uniqKey="Gross A" first="A J" last="Gross">A J Gross</name><name sortKey="Herrmann, T R W" sort="Herrmann, T R W" uniqKey="Herrmann T" first="T R W" last="Herrmann">T R W. Herrmann</name><name sortKey="Michel, M S" sort="Michel, M S" uniqKey="Michel M" first="M S" last="Michel">M S Michel</name><name sortKey="Wendt Nordahl, G" sort="Wendt Nordahl, G" uniqKey="Wendt Nordahl G" first="G" last="Wendt-Nordahl">G. Wendt-Nordahl</name></noCountry><country name="Allemagne"><region name="Hambourg"><name sortKey="Bach, T" sort="Bach, T" uniqKey="Bach T" first="T" last="Bach">T. Bach</name></region></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Terre/explor/ThuliumV1/Data/PubMed/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000527 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd -nk 000527 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Terre
|area= ThuliumV1
|flux= PubMed
|étape= Checkpoint
|type= RBID
|clé= pubmed:19184038
|texte= Feasibility and efficacy of Thulium:YAG laser enucleation (VapoEnucleation) of the prostate.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/RBID.i -Sk "pubmed:19184038" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd \
| NlmPubMed2Wicri -a ThuliumV1
| This area was generated with Dilib version V0.6.21. |  |